{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:43:03Z","timestamp":1775025783030,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00774-014-0639-x","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T23:55:00Z","timestamp":1423007700000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Chronic kidney disease and bone metabolism"],"prefix":"10.1007","volume":"33","author":[{"given":"Junichiro James","family":"Kazama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"639_CR1","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","volume":"288","author":"AM Ball","year":"2000","unstructured":"Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C (2000) Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014\u20133301","journal-title":"JAMA"},{"key":"639_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00774-012-0411-z","volume":"31","author":"M Wakasugi","year":"2013","unstructured":"Wakasugi M, Kazama JJ, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Narita I (2013) Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab 31:315\u2013321","journal-title":"J Bone Miner Metab"},{"key":"639_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"AM Alem","year":"2000","unstructured":"Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396\u2013399","journal-title":"Kidney Int"},{"key":"639_CR4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global Outcomes (KDIGO) (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"639_CR5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MNH.0b013e328362155b","volume":"22","author":"ZA Massy","year":"2013","unstructured":"Massy ZA, Dr\u00fceke TB (2013) Vascular calcification. Curr Opin Nephrol Hypertens 22:405\u2013412","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"639_CR6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","volume":"3","author":"JJ Kazama","year":"2013","unstructured":"Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int 3:446\u2013450","journal-title":"Kidney Int"},{"key":"639_CR7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T Yamashita","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494\u2013498","journal-title":"Biochem Biophys Res Commun"},{"key":"639_CR8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1507\/endocrj.48.603","volume":"48","author":"S Fukumoto","year":"2001","unstructured":"Fukumoto S, Yamashita T (2001) Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets\/osteomalacia. Endocr J 48:603\u2013610","journal-title":"Endocr J"},{"key":"639_CR9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","volume":"5","author":"P Evenepoel","year":"2010","unstructured":"Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, Vanderschueren D, Vanrenterghem Y (2010) Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 5:1268\u20131276","journal-title":"Clin J Am Soc Nephrol"},{"key":"639_CR10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378","journal-title":"Kidney Int"},{"key":"639_CR11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2011.218","volume":"8","author":"LD Quarles","year":"2012","unstructured":"Quarles LD (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8:276\u2013286","journal-title":"Nat Rev Endocrinol"},{"key":"639_CR12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8:819\u2013823","journal-title":"Clin J Am Soc Nephrol"},{"key":"639_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/17.suppl_10.2","volume":"17","author":"M Fukagawa","year":"2002","unstructured":"Fukagawa M, Kazama JJ, Kurokawa K (2002) Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant 17:2\u20135","journal-title":"Nephrol Dial Transplant"},{"key":"639_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1525-139X.2007.00308.x","volume":"20","author":"J Stubbs","year":"2007","unstructured":"Stubbs J, Liu S, Quarles LD (2007) Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 20:302\u2013308","journal-title":"Semin Dial"},{"key":"639_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000346791","volume":"180","author":"M Koizumi","year":"2013","unstructured":"Koizumi M, Komaba H, Fukagawa M (2013) Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Contrib Nephrol 180:110\u2013123","journal-title":"Contrib Nephrol"},{"key":"639_CR16","doi-asserted-by":"crossref","unstructured":"Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Fukagawa M (2006) Insufficiency of PTH action on bone in uremia. Kidney Int pp S34\u2013S36","DOI":"10.1038\/sj.ki.5001600"},{"key":"639_CR17","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1053\/ajkd.2001.27426","volume":"38","author":"M Fukagawa","year":"2001","unstructured":"Fukagawa M, Kazama JJ, Shigematsu T (2001) Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. Am J Kidney Dis 38:S152\u2013S155","journal-title":"Am J Kidney Dis"},{"key":"639_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","volume":"18","author":"JM Fraz\u00e3o","year":"2009","unstructured":"Fraz\u00e3o JM, Martins P (2009) Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens 18:303\u2013307","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"639_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/ATVBAHA.113.302525","volume":"34","author":"KA Lomashvili","year":"2014","unstructured":"Lomashvili KA, Wang X, O\u2019Neill WC (2014) Role of local versus systemic vitamin D receptors in vascular calcification. Arterioscler Thromb Vasc Biol 34:146\u2013151","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"639_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jrn.2011.10.031","volume":"22","author":"H Tanaka","year":"2012","unstructured":"Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M (2012) Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder. J Ren Nutr 22:98\u2013101","journal-title":"J Ren Nutr"},{"key":"639_CR21","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1523-1755.2004.00969.x","volume":"66","author":"H Terawaki","year":"2004","unstructured":"Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, Era S (2004) Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 66:1988\u20131993","journal-title":"Kidney Int"},{"key":"639_CR22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","volume":"48","author":"Y Iwasaki","year":"2011","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Fukagawa M (2011) Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease. Bone 48:1260\u20131267","journal-title":"Bone"},{"key":"639_CR23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","volume":"57","author":"Y Iwasaki","year":"2013","unstructured":"Iwasaki Y, Kazama JJ, Yamato H, Shimoda H, Fukagawa M (2013) Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease. Bone 57:477\u2013483","journal-title":"Bone"},{"key":"639_CR24","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.bone.2009.03.655","volume":"45","author":"S Yamamoto","year":"2009","unstructured":"Yamamoto S, Kazama JJ, Narita I, Naiki H, Gejyo F (2009) Recent progress in understanding dialysis-related amyloidosis. Bone 45:S39\u2013S42","journal-title":"Bone"},{"key":"639_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00774-005-0669-5","volume":"24","author":"JJ Kazama","year":"2006","unstructured":"Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F (2006) Abeta-2\u00a0M-amyloidosis and related bone diseases. J Bone Miner Metab 24:182\u2013184","journal-title":"J Bone Miner Metab"},{"key":"639_CR26","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1053\/ajkd.2001.27427","volume":"38","author":"JJ Kazama","year":"2001","unstructured":"Kazama JJ, Maruyama H, Gejyo F (2001) Osteoclastogenesis and osteoclast activation in dialysis-related amyloid osteopathy. Am J Kidney Dis 38:S156\u2013S160","journal-title":"Am J Kidney Dis"},{"key":"639_CR27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3109\/0886022X.2013.815102","volume":"35","author":"HK Aggarwal","year":"2013","unstructured":"Aggarwal HK, Jain D, Yadav S, Kaverappa V (2013) Bone mineral density in patients with predialysis chronic kidney disease. Ren Fail 35:1105\u20131111","journal-title":"Ren Fail"},{"key":"639_CR28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084\u20131093","journal-title":"Kidney Int"},{"key":"639_CR29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semnephrol.2003.08.012","volume":"24","author":"SM Sprague","year":"2004","unstructured":"Sprague SM, Josephson MA (2004) Bone disease after kidney transplantation. Semin Nephrol 24:82\u201390","journal-title":"Semin Nephrol"},{"key":"639_CR30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","volume":"325","author":"BA Julian","year":"1991","unstructured":"Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544\u2013550","journal-title":"N Engl J Med"},{"key":"639_CR31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","volume":"28","author":"MS Stein","year":"1996","unstructured":"Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ (1996) Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515\u2013522","journal-title":"Am J Kidney Dis"},{"key":"639_CR32","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1046\/j.1523-1755.2000.00341.x","volume":"58","author":"FP Westeel","year":"2000","unstructured":"Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A (2000) Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 58:1788\u20131796","journal-title":"Kidney Int"},{"key":"639_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","volume":"1","author":"MJ Seibel","year":"2013","unstructured":"Seibel MJ, Cooper MS, Zhou H (2013) Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol 1:59\u201370","journal-title":"Lancet Diabetes Endocrinol"},{"key":"639_CR34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1346.032","volume":"1068","author":"R Tamler","year":"2006","unstructured":"Tamler R, Epstein S (2006) Nonsteroid immune modulators and bone disease. Ann N Y Acad Sci 1068:284\u2013296","journal-title":"Ann N Y Acad Sci"},{"key":"639_CR35","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1093\/ndt\/gfr214","volume":"26","author":"R Westenfeld","year":"2011","unstructured":"Westenfeld R, Schlieper G, W\u00f6ltje M, Gawlik A, Brandenburg V, Rutkowski P, Floege J, Jahnen-Dechent W, Ketteler M (2011) Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis\u2013implications for post-transplantation bone disease. Nephrol Dial Transplant 26:4115\u20134123","journal-title":"Nephrol Dial Transplant"},{"key":"639_CR36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2013.10.010","volume":"58","author":"Y Meng","year":"2014","unstructured":"Meng Y, Zhang H, Li Y, Li Q, Zuo L (2014) Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats. Bone 58:168\u2013176","journal-title":"Bone"},{"key":"639_CR37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-011-1781-0","volume":"23","author":"SA Jamal","year":"2012","unstructured":"Jamal SA, West SL, Miller PD (2012) Fracture risk assessment in patients with chronic kidney disease. Osteoporos Int 23:1191\u20131198","journal-title":"Osteoporos Int"},{"key":"639_CR38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","volume":"7","author":"RH Yenchek","year":"2012","unstructured":"Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB, Harris TB, Newman AB, Cauley JA, Fried LF, Health, Aging, and Body Composition Study (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130\u20131136","journal-title":"Clin J Am Soc Nephrol"},{"key":"639_CR39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study. Nephrol Dial Transplant 27:345\u2013351","journal-title":"Nephrol Dial Transplant"},{"key":"639_CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","volume":"29","author":"R Amerling","year":"2010","unstructured":"Amerling R, Harbord NB, Pullman J, Feinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29:293\u2013299","journal-title":"Blood Purif"},{"key":"639_CR41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1525-139X.2007.00271.x","volume":"20","author":"PD Miller","year":"2007","unstructured":"Miller PD (2007) Is there a role for bisphosphonates in chronic kidney disease? Semin Dial 20:186\u2013190","journal-title":"Semin Dial"},{"key":"639_CR42","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","volume":"63","author":"E Hern\u00e1ndez","year":"2003","unstructured":"Hern\u00e1ndez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269\u20132274","journal-title":"Kidney Int"},{"key":"639_CR43","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","volume":"26","author":"SA Jamal","year":"2011","unstructured":"Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26:1829\u20131835","journal-title":"J Bone Miner Res"},{"key":"639_CR44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2012.06.019","volume":"60","author":"BB McCormick","year":"2012","unstructured":"McCormick BB, Davis J, Burns KD (2012) Severe hypocalcemia following denosumab injection in a hemodialysis patient. Am J Kidney Dis 60:626\u2013628","journal-title":"Am J Kidney Dis"},{"key":"639_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-013-2398-2","volume":"25","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Shiraki M, Fukunaga M, Tomomitsu T, Santora AC, Tsai R, Fujimoto G, Nakagomi M, Tsubouchi H, Rosenberg E, Uchida S (2014) Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis\u2013a double-blind, randomized, dose-finding study. Osteoporos Int 25:367\u2013376","journal-title":"Osteoporos Int"},{"key":"639_CR46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412\u2013420","journal-title":"N Engl J Med"},{"key":"639_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1744-9987.2011.00919.x","volume":"15","author":"JJ Kazama","year":"2011","unstructured":"Kazama JJ, Yamamoto S, Narita I, Kurihara S (2011) Nuclear chromatin-concentrated osteoblasts in renal bone diseases. Ther Apher Dial 15:9\u201313","journal-title":"Ther Apher Dial"},{"key":"639_CR48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.2001.01139.x","volume":"38","author":"P Ballanti","year":"2001","unstructured":"Ballanti P, Coen G, Mazzaferro S, Taggi F, Giustini M, Calabria S, Ferrannini M, Bonucci E (2001) Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate. Histopathology 38:571\u2013583","journal-title":"Histopathology"},{"key":"639_CR49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1744-9987.2011.00923.x","volume":"15","author":"JJ Kazama","year":"2011","unstructured":"Kazama JJ (2011) Bone histology in chronic kidney disease-related mineral and bone disorder. Ther Apher Dial 15:23\u201325","journal-title":"Ther Apher Dial"},{"key":"639_CR50","first-page":"145","volume":"75","author":"LD Quarles","year":"1992","unstructured":"Quarles LD, Lobaugh B, Murphy G (1992) Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145\u2013150","journal-title":"J Clin Endocrinol Metab"},{"key":"639_CR51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP63284","volume":"63","author":"A Gal-Moscovici","year":"2005","unstructured":"Gal-Moscovici A, Popovtzer MM (2005) New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 63:284\u2013289","journal-title":"Clin Nephrol"},{"key":"639_CR52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.4.5782.273","volume":"4","author":"V Parsons","year":"1971","unstructured":"Parsons V, Davies C, Goode C, Ogg C, Siddiqui J (1971) Aluminium in bone from patients with renal failure. Br Med J 4:273\u2013275","journal-title":"Br Med J"},{"key":"639_CR53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1981.149","volume":"20","author":"G Cournot-Witmer","year":"1981","unstructured":"Cournot-Witmer G, Zingraff J, Plachot JJ, Escaig F, Lef\u00e8vre R, Boumati P, Bourdeau A, Garab\u00e9dian M, Galle P, Bourdon R, Dr\u00fceke T, Balsan S (1981) Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int 20:375\u2013378","journal-title":"Kidney Int"},{"key":"639_CR54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0272-6386(12)80497-5","volume":"17","author":"JT McCarthy","year":"1991","unstructured":"McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP (1991) Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis 17:551\u2013561","journal-title":"Am J Kidney Dis"},{"key":"639_CR55","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368\u20131376","journal-title":"J Bone Miner Res"},{"key":"639_CR56","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00198-006-0087-0","volume":"17","author":"M Saito","year":"2006","unstructured":"Saito M, Fujii K, Soshi S, Tanaka T (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986\u2013995","journal-title":"Osteoporos Int"},{"key":"639_CR57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00774-007-0784-6","volume":"26","author":"M Shiraki","year":"2008","unstructured":"Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T (2008) Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 26:93\u2013100","journal-title":"J Bone Miner Metab"},{"key":"639_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11914-012-0103-6","volume":"10","author":"GE Sroga","year":"2012","unstructured":"Sroga GE, Vashishth D (2012) Effects of bone matrix proteins on fracture and fragility in osteoporosis. Curr Osteoporos Rep 10:141\u2013150","journal-title":"Curr Osteoporos Rep"},{"key":"639_CR59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00223-011-9488-y","volume":"88","author":"J Mitome","year":"2011","unstructured":"Mitome J, Yamamoto H, Saito M, Yokoyama K, Marumo K, Hosoya T (2011) Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. Calcif Tissue Int 88:521\u2013529","journal-title":"Calcif Tissue Int"},{"key":"639_CR60","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","volume":"58","author":"CO Stehman-Breen","year":"2000","unstructured":"Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200\u20132205","journal-title":"Kidney Int"},{"key":"639_CR61","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 70:1358\u20131366","journal-title":"Kidney Int"},{"key":"639_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","volume":"47","author":"MD Danese","year":"2006","unstructured":"Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47:149\u2013156","journal-title":"Am J Kidney Dis"},{"key":"639_CR63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000346223","volume":"35","author":"G Glorieux","year":"2013","unstructured":"Glorieux G, Schepers E, Pletinck A, Dhondt A, Vanholder R (2013) Review of protein-bound toxins, possibility for blood purification therapy. Blood Purif 35:45\u201350","journal-title":"Blood Purif"},{"key":"639_CR64","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1177\/0022034510377791","volume":"89","author":"AL Boskey","year":"2010","unstructured":"Boskey AL, Coleman R (2010) Aging and bone. J Dent Res 89:1333\u20131348","journal-title":"J Dent Res"},{"key":"639_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2010.12.027","volume":"58","author":"GB John","year":"2011","unstructured":"John GB, Cheng CY, Kuro-o M (2011) Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis 58:127\u2013134","journal-title":"Am J Kidney Dis"},{"key":"639_CR66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","volume":"62","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel P, Larsson TE (2013) Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis 62:339\u2013351","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-014-0639-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0639-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:16:55Z","timestamp":1559096215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-014-0639-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1007\/s00774-014-0639-x","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}